JPRN-jRCT2031200418已完成2 期
A phase 2a study of S-637880 in patients with neuropathic low back pain
agata - Tsutae0 个研究点目标入组 51 人开始时间: 2021年3月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 51
研究概览
简要总结
Since this study was prematurely terminated at all study sites, the efficacy and safety could not be fully evaluated.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 75age old（—）
- 性别
- All
入选标准
- •Patients who meet the following criteria:
- •- Patients with chronic pain located in the posterior aspect of the trunk and between the twelfth rib and the inferior end of the gluteal fold
- •- Patients whose average daily pain intensity are 4 or higher on Visit 1
- •- Patients whose weekly mean of average daily pain intensity are 4 or higher and less than 10 for 7 days including Visit 2 (Day 1) on Visit 2
排除标准
- •Patients who are considered to have primary pain other than low back and leg pain or patients with neuropathic pain other than low back and leg pain
研究者
相似试验
已完成
2 期
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
已完成
不适用
Phase I/II trial of S 81694 administered intravenously in;combination with paclitaxel to evaluate the safety,;pharmacokinetic and efficacy in metastatic breast cancer10006291metastatic breast cancerNL-OMON46450Servier R&D Benelux18
已完成
2 期
A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta ThalassemiaBeta Thalassemiainherited blood disorder10038158NL-OMON54921IMARA, Inc.15
已完成
2 期
A Phase 2b/3 study to evaluate the safety, tolerability, and effects of livoletide (AZP-531), an unacylated ghrelin analog, on food-related behaviors in patients with Prader-Willi syndromePWSNL-OMON48225Millendo Therapeutics SAS23
已完成
不适用
Phase 1 Dose Escalation Study Assessing the Safety and Pharmacokinetics of PTC518 in Healthy SubjectsNL-OMON54972PTC Therapeutics, Inc.136